Hua Han Pharmaceutical: The net profit attributable to the parent in the first half of the year was 260 million yuan, a year-on-year decrease of 24.37%.

The semi-annual report released by HA Yu Pharmaceutical on August 22nd showed that the company achieved operating income of 8.125 billion yuan in the first half of the year, a year-on-year decrease of 0.21%; net profit attributable to shareholders of the listed company was 260 million yuan, a year-on-year decrease of 24.37%; basic earnings per share was 0.1 yuan.